Targetedex vivoreduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteins
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targetedex vivoreduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteins
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 135, Issue 6, Pages 1497-1508
Publisher
Wiley
Online
2014-02-13
DOI
10.1002/ijc.28786
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivery and therapeutic potential of human granzyme B
- (2015) Florian C. Kurschus et al. IMMUNOLOGICAL REVIEWS
- Clonal architecture of chronic myelomonocytic leukemias
- (2013) R. Itzykson et al. BLOOD
- Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells
- (2013) Sonja Schiffer et al. CANCER LETTERS
- A Modified Form of Diphthamide Causes Immunotoxin Resistance in a Lymphoma Cell Line with a Deletion of theWDR85Gene
- (2013) Hui Wei et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- How to treat patients with CMML?
- (2013) Ulrich Germing et al. LEUKEMIA RESEARCH
- Design of human granzyme B variants resistant to serpin B9
- (2013) Valeria Losasso et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine model
- (2013) S Schiffer et al. Blood Cancer Journal
- Acute myeloid leukemia stem cells and CD33-targeted immunotherapy
- (2012) R. B. Walter et al. BLOOD
- The value of immunohistochemistry for CD14, CD123, CD33, myeloperoxidase and CD68R in the diagnosis of acute and chronic myelomonocytic leukaemias
- (2012) Marian A Rollins-Raval et al. HISTOPATHOLOGY
- Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice
- (2011) Amanda Nordigården et al. BRITISH JOURNAL OF HAEMATOLOGY
- HER2-targeting recombinant protein with truncated Pseudomonas Exotoxin: A translocation domain efficiently kills breast cancer cells
- (2010) Li Zhang et al. CANCER BIOLOGY & THERAPY
- Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein
- (2010) Florian Kampmeier et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA′ in a human acute myeloid leukemia xenograft tumor model
- (2010) Mehmet Kemal Tur et al. INTERNATIONAL JOURNAL OF CANCER
- Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders
- (2010) J. HALL et al. International Journal of Laboratory Hematology
- Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy
- (2009) Mrudula Mathew et al. CANCER SCIENCE
- Fcγ Receptor 1 (CD64), a Target Beyond Cancer
- (2009) T. Thepen et al. CURRENT PHARMACEUTICAL DESIGN
- Prognostic Factors in Adult Patients up to 60 Years Old With Acute Myeloid Leukemia and Translocations of Chromosome Band 11q23: Individual Patient Data–Based Meta-Analysis of the German Acute Myeloid Leukemia Intergroup
- (2009) Jürgen Krauter et al. JOURNAL OF CLINICAL ONCOLOGY
- Small Cleavable Adapters Enhance the Specific Cytotoxicity of a Humanized Immunotoxin Directed Against CD64-positive Cells
- (2009) Christian Hetzel et al. JOURNAL OF IMMUNOTHERAPY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability
- (2009) B ten Cate et al. LEUKEMIA
- The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features
- (2008) A Orazi et al. LEUKEMIA
- Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes
- (2008) B. Stahnke et al. MOLECULAR CANCER THERAPEUTICS
- Granzyme B delivery via perforin is restricted by size, but not by heparan sulfate-dependent endocytosis
- (2008) F. C. Kurschus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started